ASDs by Spray Drying: Process Development & Scale-Up

Webcast

Webcasts

Webinar Date/Time: Session 1: Tuesday, February 28th , 2023 at 4pm GMT | 11am EDT | 5pm CEST Session 2: Wednesday, March 22nd, 2023 4:00pm GMT | 11:00 am EDT | 5:00 pm CEST Session 3: Thursday, April 20th, 2023 at 4 GMT | 11am EDT | 5pm CEST

Follow the complete journey of amorphous solid dispersions (ASDs), starting from the early formulation stage to process development and scale-up, and finally to commercial reality and lifecycle management of ASDs.

Register Free: ASDs by Spray Drying: Process Development & Scale-Up

Series Overview

The Hovione team presents a new comprehensive three-part webinar series on "Amorphous Solid Dispersions by Spray Drying: from early formulation to commercial lifecycle management" starting February 28, 2023.

Over the course of this series, Hovione experts will guide participants through the complete journey of amorphous solid dispersions (ASDs), starting from the early formulation stage to process development and scale-up, and finally to commercial reality and lifecycle management of ASDs.

As an experienced manufacturer of ASDs by spray drying for the pharmaceutical industry, Hovione will be able to share its extensive knowledge and experience. Furthermore, the featured experts will be available to answer your questions during a live Q&A.

Key Learning for the Webinar Series

  • Gain knowledge on designing a successful formulation for Amorphous Solid Dispersions produced by Spray Drying
  • Discover how to develop a robust process at lab scale and assure a successful scale-up
  • Learn how to use a model-based methodology to establish the design space and a commercial process
  • Understand what to consider during the Lifecycle Management of a commercial Amorphous Solid Dispersion by Spray Drying

Featured Speakers

Clara Sá Couto, Ph.D.
Manager
R&D Oral Drug Product - Process
Development Team | Hovione

Clara Sá Couto, Ph.D.is part of the R&D Oral Drug Product Development group. She is the Process Development team Manager who is responsible for the development of Spray Drying and Tableting late-stage programs for oral delivery. She joined Hovione in 2016 as a Scientist, and she began her focus on particle engineering and solubility enhancement programs. She has been involved in several spray drying processes from early stages until validation. Between 2018 and 2022 she managed the Operations team within the Oral Drug Product Development group, which was responsible for providing support to all of the activities related to the laboratorial process development that covered areas such as inhalation, pre-formulation, ASD screening, spray drying, and roller compaction/tableting (batch and continuous).

Clara holds a Ph.D. in Refining, Petrochemical and Chemical Engineering and is the author of five papers and one patent.

Josè Luís Santos, Ph.D.
Director
Technology Intensification |
Hovione

José Luís Santos, Ph.D. joined Hovione 12 years ago and has evolved from R&D engineer (developing processes across all scales of spray drying) to the business area, becoming a Senior Manager for Particle Engineering Services. He led the company's Knowledge Management and Innovation areas for two years, and in between 2018 and 2021 he was based at Hovione’s site in the USA to support the installation, qualification, and kick-off of the GMP operations of a new Continuous Manufacturing rig. In 2021 he took on the role of Director of the Continuous Tableting Center for Excellence, based in Lisbon, overseeing the company's drug product Continuous Manufacturing efforts across all sites. In 2022, José moved on to become the Director of Technology Intensification, with the goal of maintaining Hovione among the world’s leading organizations in spray drying and continuous tableting services. José holds a Ph.Din Chemical Engineering. He has extensive senior management experience over two geographies (Portugal and USA) and he is the author of sixteen papers, one book chapter, and four patents.

Register Free: ASDs by Spray Drying: Process Development & Scale-Up

Recent Videos
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content